BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2917130)

  • 1. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
    Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
    Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
    Boisclair MD; Ireland H; Lane DA
    Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
    Moresco RN; Vargas LC; Voegeli CF; Santos RC
    J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS; Kim YA; Kim HK; Park Q
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
    Stokol T; Erb HN; De Wilde L; Tornquist SJ; Brooks M
    Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
    Carr JM; McKinney M; McDonagh J
    Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
    Stokol T; Brooks MB; Erb HN; Mauldin GE
    Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K; Sakurai G; Baba M
    Thromb Res; 1992 May; 66(2-3):179-89. PubMed ID: 1412191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
    Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A test for the detection of fibrin in the plasma].
    Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
    Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
    Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of FDP-D-dimer in DIC and pre-DIC].
    Takagi M; Wada H; Tanigawa M; Iwasaki E; Deguchi A; Mori Y; Suzuki H; Ohkubo I; Endou T; Deguchi K
    Rinsho Byori; 1990 Jul; 38(7):806-12. PubMed ID: 2205744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.